| |
 |
|
|
|
|
| Fujisawa Pharmaceutical Revised List of Ethical Drug Products Currently Under Development |
|
|
|
Tokyo, Feb 27, 2004 (JCN) - Fujisawa Pharmaceutical has revised the list of ethical drug products currently under development.
The list shows that the company is now developing a total of 16 different products: seven in Japan, 10 in the US and four in EU. Details are available at http://www.fujisawa.co.jp/english/ir/release/e040225.pdf
Copyright © 2013 JCN. All rights reserved. A division of Japan Corporate News Network KK.
 Company Profile |  Print |  Alerts
|
|
|
Mega Pharmaceutical Astellas Pharma Kicks Off Operations
(Apr 1, 2005)
|
|
|
Fujisawa Pharmaceutical to Outsource Cefzon Bulk Production to API Corporation
(Mar 25, 2005)
|
|
|
Fujisawa Pharmaceutical to Contract Out Home Healthcare Business to Teijin Pharma
(Mar 7, 2005)
|
|
|
Fujisawa Pharmaceutical, Carlsson Research Conclude Licensing Agreement for Antipsychotic Agent ACR-16
(Feb 8, 2005)
|
|
|
Yamanouchi to Spin Off Formulation Plants
(Nov 10, 2004)
|
|
|
Yamanouchi Pharmaceutical, Fujisawa Pharmaceutical Develop Business Philosphy, Logo, and Corporate Messages for Their Merging Entity Astellas
(Sept 16, 2004)
|
|
|
Fujisawa Completes Construction of New Formulation Facilities for Micafungin
(Aug 3, 2004)
|
|
|
Fujisawa and Yamanouchi Will Establish Zepharma Inc., an OTC Pharmaceutical Company
(May 17, 2004)
|
|
|
Fujisawa Pharmaceutical Revised List of Ethical Drug Products Currently Under Development
(Feb 27, 2004)
|
|
|
Yamanouchi and Fujisawa to Merge
(Feb 24, 2004)
|
|
|
|
|
|
|
Otsuka Launches First Skin Patch Treatment for Parkinson's Disease and Restless Legs Syndrome (Feb 22, 2013)
|
|
|
Teijin Launches Polyester Curtain Fabric with Enhanced Pollen-trapping (Feb 21, 2013)
|
|
|
Toyota Tsusho Opens Medical Clinic in Thai Plant (Feb 18, 2013)
|
|
|
Daiichi Sankyo Develops Nucleic Acid Treatment for Duchenne Muscular Dystrophy (Feb 15, 2013)
|
|
|
Dainippon Sumitomo Pharma Opens Subsidiary in Singapore (Jan 22, 2013)
|
|
|
Teijin and InCube Labs Enter Strategic Partnership in Healthcare Business (Jan 22, 2013)
|
|
|
Chugai Grants Debiopharm Group Exclusive Worldwide License for Anti-cancer Agent (Jan 9, 2013)
|
|
|
Takara Bio Initiates Phase 1 HIV Gene Therapy Clinical Trial (Jan 7, 2013)
|
|
|
Kobe University, KNC Labs and Dainippon Sumitomo to Research Anti-cancer Agent (Dec 28, 2012)
|
|
|
Daiichi Sankyo Introduces Alzheimer's Disease Awareness Campaign (Dec 20, 2012)
|
More Drugs & OTC news...
|
|
|
|
|
|
Otsuka Launches First Skin Patch Treatment for Parkinson's Disease and Restless Legs Syndrome (Feb 22, 2013)
|
|
|
Teijin Launches Polyester Curtain Fabric with Enhanced Pollen-trapping (Feb 21, 2013)
|
|
|
Toyota Tsusho Opens Medical Clinic in Thai Plant (Feb 18, 2013)
|
|
|
Daiichi Sankyo Develops Nucleic Acid Treatment for Duchenne Muscular Dystrophy (Feb 15, 2013)
|
|
|
Dainippon Sumitomo Pharma Opens Subsidiary in Singapore (Jan 22, 2013)
|
|
|
Teijin and InCube Labs Enter Strategic Partnership in Healthcare Business (Jan 22, 2013)
|
|
|
Chugai Grants Debiopharm Group Exclusive Worldwide License for Anti-cancer Agent (Jan 9, 2013)
|
|
|
Takara Bio Initiates Phase 1 HIV Gene Therapy Clinical Trial (Jan 7, 2013)
|
|
|
Kobe University, KNC Labs and Dainippon Sumitomo to Research Anti-cancer Agent (Dec 28, 2012)
|
|
|
Daiichi Sankyo Introduces Alzheimer's Disease Awareness Campaign (Dec 20, 2012)
|
More Drugs & OTC news...
|
|
|
|
|
|
|
|
|
|
